ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,461Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 26

$564K Total Retail Price of All Prescriptions

Rank: 2 out of 26

506 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,485 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 436 325 1 8
SIMVASTATIN 429 309 2 1
LISINOPRIL 425 306 3 2
LEVOTHYROXINE SODIUM 338 285 4 4
METOPROLOL TARTRATE 290 255 5 10
FUROSEMIDE 269 228 6 9
AMLODIPINE BESYLATE 263 227 7 3
POTASSIUM CHLORIDE 229 157 8 25
WARFARIN SODIUM 216 210 9 14
METOPROLOL SUCCINATE 211 145 10 11
HYDROCODONE-ACETAMINOPHEN 186 143 S3 11 13
HYDROCHLOROTHIAZIDE 186 153 11 6
GABAPENTIN 183 118 13 18
TRAMADOL HCL 176 71 14 16
RANITIDINE HCL 172 136 15 36
MIRTAZAPINE 146 125 16 39
ATORVASTATIN CALCIUM 145 103 17 5
ATENOLOL 145 112 17 15
ALENDRONATE SODIUM 143 136 19 22
METFORMIN HCL 139 102 20 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 115 21 17
ALLOPURINOL 133 92 22 42
PANTOPRAZOLE SODIUM 129 88 23 24
LOVASTATIN 128 119 24 33
NEXIUM 122 62 25 27
PRAVASTATIN SODIUM 118 79 26 20
PAROXETINE HCL 110 71 27 40
TAMSULOSIN HCL 109 94 28 35
CITALOPRAM HBR 107 92 29 21
LOSARTAN POTASSIUM 103 85 30 12
METFORMIN HCL ER 101 75 31 43
SERTRALINE HCL 98 83 32 19
DIOVAN 87 62 33 29
LOSARTAN-HYDROCHLOROTHIAZIDE 85 75 34 26
ADVAIR DISKUS 80 32 35 56
DILTIAZEM 24HR CD 71 58 36 75
TRIAMTERENE-HCTZ 71 54 36 50
PROAIR HFA 71 30 36 45
ZETIA 70 58 39 76
DIGOXIN 70 70 39 76
VENLAFAXINE HCL ER 69 12 41 78
AMITRIPTYLINE HCL 68 45 R 42 54
ZOLPIDEM TARTRATE 68 61 42 31
CARVEDILOL 67 42 44 34
TRICOR 66 58 45 79
GLIPIZIDE XL 65 40 46 80
MELOXICAM 65 43 46 53
SPIRIVA 64 45 48 81
FENOFIBRATE 63 43 49 40
CLOPIDOGREL 60 51 50 61
OXYBUTYNIN CHLORIDE 59 47 51 85
GLIMEPIRIDE 58 52 52 30
CRESTOR 58 51 52 23
TRAZODONE HCL 56 17 54 32
NIASPAN 55 22 55 63
CARBIDOPA-LEVODOPA 54 54 56 90
BENAZEPRIL HCL 52 52 57 57
POLYETHYLENE GLYCOL 3350 52 28 57 93
FLUTICASONE PROPIONATE 52 32 57 37
DIOVAN HCT 51 42 60 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 7, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.